Sidmak

Valsad, India Founded: 1983 • Age: 43 yrs
Develops and manufactures pharmaceutical compositions

About Sidmak

Sidmak is a Healthcare company based in Valsad (India) founded in 1983. It develops and manufactures pharmaceutical compositions. The company has 320 employees. Its Indian entity Sidmak Laboratories (India) Private Limited reported revenue of β‚Ή86.22 Cr. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas.

Company details

Sidmak was founded in 1983 and is based in Valsad, India, within the pharmaceuticals sector. Operations focus on the development and manufacture of compositions, particularly those involving cyclosporine for immunosuppressive uses and anticancer formulations for oncology applications. Various delivery systems and therapeutic indications are addressed through these activities, supporting global pharmaceutical needs.

  • Headquarters Valsad, India
  • Employees 320
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website sidmak.com
  • Legal Name Sidmak Laboratories (India) Private Limited
  • Date of Incorporation 06 May, 1983
  • Jurisdiction Valsad, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹86.22 Cr

    FY 2026 · +1% YoY

  • Net Profit
    ₹13.16 Cr

    FY 2026 · 16% margin

  • EBITDA
    ₹17.82 Cr

    FY 2026 · 22% margin

  • Latest Funding Round
    $1.9M (USD), Unspecified

    Oct 2024

  • Investors
    Sun Pharma

    & 3 more

  • Employee Count
    320

Funding Insights of Sidmak

  • Total Rounds 2
  • Last Round Unspecified β€” $1.9M
  • First Round $989,925

    (Apr 2010)

  • Investors Count 4

All 2 funding rounds of Sidmak with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2024$1.9MUnspecified–Mackinonenterprise
Apr 2010$989,925Unspecified–nirmitexports
–
Valuation history

4 investors in total: 4 institutional.

Investors in Sidmak

Sidmak has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Sun Pharma, Mackinonenterprise and Shanghavi Finance.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983sunpharma.comMumbai, India
Premium access

Investor details for Sidmak

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Sidmak Laboratories (India) Private Limited (Sidmak)

Sidmak Laboratories (India) Private Limited is the primary company behind Sidmak. The board of Sidmak Laboratories (India) Private Limited currently have 6 directors; the longest-serving is Vinayak Tulsidas Bhalani, appointed in 1996. 13 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vinayak Tulsidas Bhalani
DIN 02747430
Director26 Sep 199630 yrs 1 moSidmak Laboratories (India) Private Limited
Udaykumar Ratilal Shah
DIN 00098932
Whole-time director01 Aug 201412 yrs 3 moSidmak Laboratories (India) Private Limited
Raj Jaysingh Kariya
DIN 10221699
Director12 Apr 20242 yrs 6 moSidmak Laboratories (India) Private Limited
Rajiv Chhelshankar Pandya
DIN 07271988
Director12 Apr 20242 yrs 6 moSidmak Laboratories (India) Private Limited
Swati Chetan Jagetia
DIN 08610199
Director28 May 20251 yr 5 moSidmak Laboratories (India) Private Limited
Ashok Indulal Bhuta
DIN 00065307
Director18 Dec 202510 moSidmak Laboratories (India) Private Limited

People of Sidmak

1 people are tracked at Sidmak (1 in leadership); the tracked headcount is 320.

NameRoleGroup
Owner & DirectorLeadership
Premium access

Complete people profiles for Sidmak

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Sidmak

Figures of Sidmak Laboratories (India) Private Limited, the primary company behind Sidmak, for FY 2026. Revenue was ₹86.22 Cr (+1% year on year). Net profit was ₹13.16 Cr (16% margin). EBITDA was ₹17.82 Cr (22% margin). Revenue has grown at a compounded annual rate of +6% over three years and -3% over five years.

  • ₹86.22 CrRevenue · FY 2026 · +1% YoY
  • ₹13.16 CrNet profit · 16% margin
  • ₹17.82 CrEBITDA · 22% margin
  • ₹5.00 CrPaid-up capital
  • 402Employees (provident fund records)
  • +6%Revenue CAGR, 3 years
  • -3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sidmak Laboratories (India) Private Limited are on its company page.

Premium access

Detailed financial statements for Sidmak

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Sidmak

3 dated milestones of Sidmak across 41 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sidmak is founded.
  2. Funding First funding round of $990K.
  3. Funding Latest funding round, Unspecified, of $1.9M.

Web traffic of Sidmak

The website of Sidmak (sidmak.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▼ 25.1% vs previous month

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Sidmak (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 89.42 M962
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, IndiaUSD 508.93 M4,050
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, IndiaUSD 6.44 B19,801
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sidmak

Sidmak was founded in 1983 and raised its 1st funding round 27 years after it was founded.

Sidmak is headquartered in Valsad, India. It is registered at Valsad, Gujarat, India.

Sidmak has 320 employees.

The primary company behind Sidmak, Sidmak Laboratories (India) Private Limited, reported revenue of β‚Ή86.22 Cr for FY 2026, up 1% year on year.

Sidmak was founded in 1983 and is based in Valsad, India, within the pharmaceuticals sector. Operations focus on the development and manufacture of compositions, particularly those involving cyclosporine for immunosuppressive uses and anticancer formulations for oncology applications. Various delivery systems and therapeutic indications are addressed through these activities, supporting global pharmaceutical needs.

Sidmak has 4 investors. Key investors include Sun Pharma, Mackinonenterprise, Shanghavi Finance, and nirmitexports.

Sidmak operates through Sidmak Laboratories (India) Private Limited.

The legal entities of Sidmak currently have 6 directors, including Ashok Indulal Bhuta, Vinayak Tulsidas Bhalani, Udaykumar Ratilal Shah and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available